ALG11 anticorps

N° du produit ABIN634995

Cet anticorps anti-ALG11 est un anticorps Lapin Polyclonal détectant ALG11 dans WB. Adapté pour Humain, Souris et Rat.

Aperçu rapide pour ALG11 anticorps (ABIN634995)

Antigène: ALG11 (Asparagine-Linked Glycosylation 11, alpha-1,2-Mannosyltransferase Homolog (Yeast) (ALG11))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ALG11 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-ALG11 anticorps

Specificité: ALG11 antibody was yeast alpha-12-mannosyltransferase

Purification: Affinity purified

Immunogène: ALG11 antibody was raised using a synthetic peptide corresponding to a region with amino acids LSEDLGVQEYVEFKINIPFDELKNYLSEATIGLHTMWNEHFGIGVVECMA

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

ALG11 Blocking Peptide, (ABIN5612018), is also available for use as a blocking control in assays to test for specificity of this ALG11 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of ALG11 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur ALG11

Antigène: ALG11 (Asparagine-Linked Glycosylation 11, alpha-1,2-Mannosyltransferase Homolog (Yeast) (ALG11))

Autre désignation: ALG11

Sujet: ALG11 is a GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase which is localized to the cytosolic side of the endoplasmic reticulum (ER) and catalyzes the transfer of the fourth and fifth mannose residue from GDP-mannose (GDP-Man) to Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol resulting in the production of Man5GlcNAc2-PP-dolichol. Mutations in this gene are associated with congenital disorder of glycosylation type Ip (CDGIP).

Poids moléculaire: 56 kDa (MW of target protein)

Pathways: SARS-CoV-2 Protein Interactome